[Alpha Biz= Kim Jisun] SD Biosensor announced on May 20 that it has decided to sell its Bundang office building to secure liquidity and finance future business initiatives. According to the regulatory filing, the transaction amount is KRW 100 billion (approximately USD 73 million), equivalent to about 2.6% of the company’s total assets as of last year (KRW 3.89 trillion).
The buyer is Capstone Asset Management. Under the terms of the deal, SD Biosensor will receive KRW 88 billion by May 30, with the remaining KRW 12 billion to be paid in 24 months.
The company stated that the sale is aimed at bolstering cash reserves and preparing for strategic investments, including a new platform expected to be unveiled later this year and potential mergers and acquisitions (M&A) in the future.
“This asset sale was made to secure funds for the development of a new platform, which is scheduled to be launched by the end of this year, as well as for upcoming M&A opportunities,” a company official explained.
In the first quarter of 2025, SD Biosensor reported revenue of KRW 185.3 billion, with an operating loss of KRW 14.6 billion and a net loss of KRW 18.8 billion.
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
